Confirming Permanent Lack of Blood Flow to the Brain During A-NRP DCC Organ Transplant
CONCLUDE
Confirming the Permanent Cessation of Intracranial Circulation During Abdominal Normothermic Regional Perfusion After the Determination of Death by Circulatory Criteria
1 other identifier
observational
30
1 country
2
Brief Summary
This study aims to evaluate the surgical technique used in Abdominal Normothermic Regional Perfusion (A-NRP) in death determination by circulatory criteria (DCC) organ donors. The proposed study will demonstrate that there is no resumption of brain blood flow or activity during the A-NRP procedure. This will be assessed using multimodal neuromonitoring protocol that enables continuous focused monitoring of brain blood flow and activity during A-NRP. This will provide evidence that brain blood flow and activity does not resume during NRP and ensure donor safety in using this technique in standard of care practice.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Apr 2024
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 16, 2023
CompletedFirst Posted
Study publicly available on registry
June 1, 2023
CompletedStudy Start
First participant enrolled
April 2, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedApril 24, 2024
April 1, 2024
1.2 years
May 16, 2023
April 22, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Donor resumption of brain blood flow and/or activity
Proportion of enrolled patients who have resumption of brain blood flow and/or activity during A-NRP on any neuromonitor and that is confirmed by neurocritical care physician and that results in termination of A-NRP
Through study completion, an average of 1 year
Secondary Outcomes (5)
Donor accrual rate
Through study completion, an average of 1 year
Consent rate
Through study completion, an average of 1 year
Neuromonitoring modalities
Through study completion, an average of 1 year
Duration and proportion of neuromonitoring signal
Through study completion, an average of 1 year
Neuromonitoring failure
Through study completion, an average of 1 year
Study Arms (1)
DCC Donors
Standard criteria DCC donors will be undergoing the A-NRP perfusion process to recondition organs prior to procurement. Multimodal neuromonitors will be placed on the donor prior to withdrawal of life support and readings will be recorded during the withdrawal process and for the duration of the A-NRP perfusion process. The neuromonitoring team will be looking for evidence of brain blood flow or activity.
Interventions
Multimodal neuromonitoring will include: Transcranial colour-coded Doppler (TCCD), Electroencephalography (EEG), and Somatosensory evoked potentials (SSEP) or brainstem auditory evoked potentials (BAEP)
Eligibility Criteria
Patients in critical care at participating study centers who qualify for DCC organ donation and whose families/surrogate decision makers have consented to DCC organ donation according to current criteria of the participating transplant programs.
You may qualify if:
- ≤ 18 years of age
You may not qualify if:
- \< 18 years of age
- DCC donors who proceed to donation following medical assistance in dying or those who are able to provide first-person consent at the time of donation
- Injuries that anatomically preclude the use of neurological monitoring
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Western University, Canadalead
- University Health Network, Torontocollaborator
Study Sites (2)
London Health Sciences Centre
London, Ontario, N6A 5A5, Canada
Toronto Western Hospital
Toronto, Ontario, M5T 2S8, Canada
Study Officials
- PRINCIPAL INVESTIGATOR
Anton Skaro, MD PhD
London Health Sciences Centre/Lawson Health Research Institute
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Liver Transplantation Surgery and Associate Professor - Department of Surgery
Study Record Dates
First Submitted
May 16, 2023
First Posted
June 1, 2023
Study Start
April 2, 2024
Primary Completion
June 1, 2025
Study Completion
December 1, 2025
Last Updated
April 24, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share